CDMO Pipeline (Confidential Molecules)
Various (Oncology, Critical Care)
Phase 1 to CommercialActive
Key Facts
Indication
Various (Oncology, Critical Care)
Phase
Phase 1 to Commercial
Status
Active
Company
About Gland Pharma
Founded in 1978, Gland Pharma has grown into one of the world's largest injectable-focused companies, renowned for its high-quality manufacturing and extensive product portfolio. The company is majority-owned by Shanghai Fosun Pharmaceutical and has a significant presence in the US market through its subsidiary in Princeton, New Jersey. Its strategic focus includes expanding its CDMO services, developing complex injectable products, and leveraging its expertise in biologics and sterile injectables to drive growth in key therapeutic areas.
View full company profile